Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents-Reference-Cited by-同舟云学术

Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents

Published:2018-12 Issue:24 Volume:11 Page:2467-2476
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Konigstein Maayan,Ben-Yehuda Ori,Smits Pieter C.,Love Michael P.,Banai Shmuel,Perlman Gidon Y.,Golomb Mordechai,Ozan Melek Ozgu,Liu Mengdan,Leon Martin B.,Stone Gregg W.,Kandzari David E.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials;Cutlip;Circulation,2004

2. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents;Iakovou;JAMA,2005

3. Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials);Lee;Am J Cardiol,2006

4. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era;Iijima;Am Heart J,2007

5. Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents;Billinger;Am Heart J,2012

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Sweet and Heavy Affair: Glucose, Epicardial Fat, and Heart Trouble;Academic Radiology;2024-08

2. Stent Failure After Percutaneous Coronary Intervention in Diabetes Mellitus;Journal of the American College of Cardiology;2024-07

3. Development, validation and visualization of a web-based nomogram for predicting risk of new-onset diabetes after percutaneous coronary intervention;Scientific Reports;2024-06-13

4. Association between diabetes mellitus and primary restenosis following endovascular treatment: a comprehensive meta-analysis of randomized controlled trials;Cardiovascular Diabetology;2024-04-22

5. Cardiorenal outcomes and mortality after sodium‐glucose cotransporter‐2 inhibitor initiation in type 2 diabetes patients with percutaneous coronary intervention history;Diabetes, Obesity and Metabolism;2024-04-21